TY - JOUR
T1 - Identification and functional characterization of nuclear mortalin in human carcinogenesis
AU - Ryu, Jihoon
AU - Kaul, Zeenia
AU - Yoon, A. Rum
AU - Liu, Ye
AU - Yaguchi, Tomoko
AU - Na, Youjin
AU - Ahn, Hyo Min
AU - Gao, Ran
AU - Choi, Il Kyu
AU - Yun, Chae Ok
AU - Kaul, Sunil C.
AU - Wadhwa, Renu
N1 - Publisher Copyright:
© 2014 by The American Society for Biochemistry and Molecular Biology Inc.
PY - 2014
Y1 - 2014
N2 - The Hsp70 family protein mortalin is an essential chaperone that is frequently enriched in cancer cells and exists in various subcellular sites, including the mitochondrion, plasma membrane, endoplasmic reticulum, and cytosol. Although the molecular mechanisms underlying its multiple subcellular localizations are not yet clear, their functional significance has been revealed by several studies. In this study, we examined the nuclear fractions of human cells and found that the malignantly transformed cells have more mortalin than the normal cells. We then generated a mortalin mutant that lacked a mitochondrial targeting signal peptide. It was largely localized in the nucleus, and, hence, is called nuclear mortalin (mot-N). Functional characterization of mot-N revealed that it efficiently protects cancer cells against endogenous and exogenous oxidative stress. Furthermore, compared with the full-length mortalin overexpressing cancer cells, mot-N derivatives showed increased malignant properties, including higher proliferation rate, colony forming efficacy, motility, and tumor forming capacity both in in vitro and in vivo assays. We demonstrate that mot-N promotes carcinogenesis and cancer cell metastasis by inactivation of tumor suppressor protein p53 functions and by interaction and functional activation of telomerase and heterogeneous ribonucleoprotein K (hnRNP-K) proteins.
AB - The Hsp70 family protein mortalin is an essential chaperone that is frequently enriched in cancer cells and exists in various subcellular sites, including the mitochondrion, plasma membrane, endoplasmic reticulum, and cytosol. Although the molecular mechanisms underlying its multiple subcellular localizations are not yet clear, their functional significance has been revealed by several studies. In this study, we examined the nuclear fractions of human cells and found that the malignantly transformed cells have more mortalin than the normal cells. We then generated a mortalin mutant that lacked a mitochondrial targeting signal peptide. It was largely localized in the nucleus, and, hence, is called nuclear mortalin (mot-N). Functional characterization of mot-N revealed that it efficiently protects cancer cells against endogenous and exogenous oxidative stress. Furthermore, compared with the full-length mortalin overexpressing cancer cells, mot-N derivatives showed increased malignant properties, including higher proliferation rate, colony forming efficacy, motility, and tumor forming capacity both in in vitro and in vivo assays. We demonstrate that mot-N promotes carcinogenesis and cancer cell metastasis by inactivation of tumor suppressor protein p53 functions and by interaction and functional activation of telomerase and heterogeneous ribonucleoprotein K (hnRNP-K) proteins.
UR - https://www.scopus.com/pages/publications/84906980711
U2 - 10.1074/jbc.M114.565929
DO - 10.1074/jbc.M114.565929
M3 - Article
C2 - 25012652
AN - SCOPUS:84906980711
SN - 0021-9258
VL - 289
SP - 24832
EP - 24844
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 36
ER -